AHA Updates Treatment Guidelines for Atrial Fibrillation
|
By HospiMedica International staff writers Posted on 04 Feb 2019 |
|
Image: New research shows NOACs are preferred over warfarin as an anticoagulant in AF (Photo courtesy of 123RF).
The American Heart Association (AHA; Dallas, TX, USA), American College of Cardiology (ACC; Washington, DC, USA), and the Heart Rhythm Society (HRS; Washington, DC, USA) now recommend the use of non-vitamin K oral anticoagulants (NOACs) over traditional warfarin to prevent stroke in people with atrial fibrillation (AF).
The recommendations are the result of a focused update to the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation. The new guideline also suggests that NOACs could even be used in people at a lower risk of stroke than previously thought, with emerging research suggesting the benefit of NOACs in stroke reduction risk outweighs the risk of taking them. The recommendation was simultaneously published on January 29, 2019, in Circulation, the Journal of the American College of Cardiology (JACC), and HeartRhythm.
“Patients with atrial fibrillation are at increased risk of stroke, which can be devastating. A goal of treating AF patients is to make blood less likely to form clots, which reduces the risk of stroke,” said Craig T. January, MD, PhD, co-chair of the updated guideline committee. “NOACs may be safer for patients because there is less risk of bleeding, and they may also be more effective at preventing blood clots than warfarin. AF patients should talk to their healthcare provider about any concerns they have about their prescribed medications and whether or not losing weight would benefit their health.”
Until the introduction of NOACs, warfarin had been one of the only treatment options for long-term anticoagulation of patients with AF, venous thromboembolism (VTE), or other conditions that require chronic anticoagulation. The major benefit of the NOAC anticoagulants is that they do not require strict and frequent laboratory monitoring, dosing adjustments, or dietary restrictions, and incur fewer drug interactions than warfarin. NOACs include dabigatran, rivaroxaban, apixaban, and edoxaban.
Related Links:
American Heart Association
American College of Cardiology
Heart Rhythm Society
The recommendations are the result of a focused update to the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation. The new guideline also suggests that NOACs could even be used in people at a lower risk of stroke than previously thought, with emerging research suggesting the benefit of NOACs in stroke reduction risk outweighs the risk of taking them. The recommendation was simultaneously published on January 29, 2019, in Circulation, the Journal of the American College of Cardiology (JACC), and HeartRhythm.
“Patients with atrial fibrillation are at increased risk of stroke, which can be devastating. A goal of treating AF patients is to make blood less likely to form clots, which reduces the risk of stroke,” said Craig T. January, MD, PhD, co-chair of the updated guideline committee. “NOACs may be safer for patients because there is less risk of bleeding, and they may also be more effective at preventing blood clots than warfarin. AF patients should talk to their healthcare provider about any concerns they have about their prescribed medications and whether or not losing weight would benefit their health.”
Until the introduction of NOACs, warfarin had been one of the only treatment options for long-term anticoagulation of patients with AF, venous thromboembolism (VTE), or other conditions that require chronic anticoagulation. The major benefit of the NOAC anticoagulants is that they do not require strict and frequent laboratory monitoring, dosing adjustments, or dietary restrictions, and incur fewer drug interactions than warfarin. NOACs include dabigatran, rivaroxaban, apixaban, and edoxaban.
Related Links:
American Heart Association
American College of Cardiology
Heart Rhythm Society
Latest Critical Care News
- Smart Bandages to Revolutionize Treatment of Chronic Wounds
- Portable System for Warming Blood and IV-Fluids Reduces Hypothermia Risk in Hemorrhaging Patients
- AI-Generated Real-Time Alerts for Declining Health Speeds Up Treatment and Reduces Hospital Deaths
- Breakthrough Computational Method Predicts Sudden Cardiac Death
- Ingestible Microbiome Sampling Pill to Help Diagnose Wide Range of Health Conditions
- GPS-Like Smart Pills with AI Provide Real-Time 3D Monitoring Of Gastrointestinal Health
- Bioengineering Breakthrough to Improve Bone Regeneration Treatments
- Soft Robots with Electronic Skins and Artificial Muscles to Provide Medical Treatment
- AI Camera Technology Helps Doctors Quickly Assess Severity of Infections
- Machine Learning Delivers Personalized Oxygenation for Patients on Ventilators
- New AI Algorithm Detects Rare Epileptic Seizures from EEG Data
- Facial Thermal Imaging Combined with AI Predicts Coronary Artery Disease
- AI Technology Predicts Cardiac Events 10 Years in Advance
- Recyclable ‘Smart Skin’ Monitors Biological Signals on Demand
- Novel Catheter to Reduce Risk for Associated Urinary Tract Infections and Sepsis
- AI Doubles Medical Professionals’ Accuracy in Reading EEG Charts of ICU Patients
Channels
Surgical Techniques
view channel
Electronic Grid Records Brain Activity during Surgery to Minimize Damage to Healthy Tissue
A new electronic grid equipped with nanoscale sensors that records electrical signals from the human brain with unprecedented detail could enhance surgical planning and execution for removing brain tumors... Read more
Total Robotic Metabolic and Bariatric Surgery Proves More Beneficial than Conventional Laparoscopy
According to the U.S. Centers for Disease Control and Prevention (CDC), 42.4% of Americans are affected by obesity. Research indicates that obesity can compromise the immune system, trigger chronic inflammation,... Read more
Wirelessly Activated Robotic Device Aids Digestion in Patients with Compromised Organs
The transport of fluids and solids is essential in the human body, driven by a wave-like movement in the lumen known as peristalsis. However, peristalsis can be disrupted in patients who have obstructions... Read more
Patient Care
view channel
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more
Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization
An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more
Game-Changing Innovation in Surgical Instrument Sterilization Significantly Improves OR Throughput
A groundbreaking innovation enables hospitals to significantly improve instrument processing time and throughput in operating rooms (ORs) and sterile processing departments. Turbett Surgical, Inc.... Read more
Health IT
view channel
Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients
Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more
Strategic Collaboration to Develop and Integrate Generative AI into Healthcare
Top industry experts have underscored the immediate requirement for healthcare systems and hospitals to respond to severe cost and margin pressures. Close to half of U.S. hospitals ended 2022 in the red... Read more
AI-Enabled Operating Rooms Solution Helps Hospitals Maximize Utilization and Unlock Capacity
For healthcare organizations, optimizing operating room (OR) utilization during prime time hours is a complex challenge. Surgeons and clinics face difficulties in finding available slots for booking cases,... Read more
AI Predicts Pancreatic Cancer Three Years before Diagnosis from Patients’ Medical Records
Screening for common cancers like breast, cervix, and prostate cancer relies on relatively simple and highly effective techniques, such as mammograms, Pap smears, and blood tests. These methods have revolutionized... Read morePoint of Care
view channel
POCT for Infectious Diseases Delivers Laboratory Equivalent Pathology Results
On-site pathology tests for infectious diseases in rural and remote locations can achieve the same level of reliability and accuracy as those conducted in hospital laboratories, a recent study suggests.... Read more
Cartridge-Based Hemostasis Analyzer System Enables Faster Coagulation Testing
Quickly assessing a patient's total hemostasis status can be critical to influencing clinical outcomes and using blood products. Haemonetics Corporation (Boston, MA, USA) has now obtained 510(k) clearance... Read more
Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing
Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Business
view channel
BD Acquires Edwards Lifesciences' Critical Care Product Group for USD 4.2 Billion
BD (Becton, Dickinson and Company, Franklin Lakes, NJ, USA) and Edwards Lifesciences (Irvine, CA, USA) have entered into a definitive agreement under which BD will acquire Edwards' Critical Care product... Read more
